Cargando…

Towards precision management of cardiovascular patients with COVID-19 to reduce mortality

Detalles Bibliográficos
Autores principales:	Zhou, Kehua, Yang, Shujuan, Jia, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186125/ https://www.ncbi.nlm.nih.gov/pubmed/32353374 http://dx.doi.org/10.1016/j.pcad.2020.04.012

Ejemplares similares

Cardiovascular Manifestations and Mechanisms in Patients with COVID-19
por: Dou, Qingyu, et al.
Publicado: (2020)

Associations between nighttime light and COVID-19 incidence and mortality in the United States
por: Zhang, Yiming, et al.
Publicado: (2022)

The epidemiology, pathophysiological mechanisms, and management toward COVID-19 patients with Type 2 diabetes: A systematic review
por: Yin, Yun, et al.
Publicado: (2021)

Reduced Vascular Practice and Increased Cardiovascular Mortality for COVID-19–Negative Patients
por: Bozzani, Antonio, et al.
Publicado: (2022)

Towards precision medicine: Omics approach for COVID-19
por: Cen, Xiaoping, et al.
Publicado: (2023)

Impact of obesity on COVID-19 patients
por: Yu, Wanqi, et al.
Publicado: (2021)

Cardiovascular risk assessment: The key path toward precision prevention
por: Li, Jianxin, et al.
Publicado: (2023)

Trends in Cardiovascular Disease Mortality: Can We Prevent PRECISELY?
por: Sung, Ki-Chul
Publicado: (2021)

Influenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19: JACC State-of-the-Art Review
por: Behrouzi, Bahar, et al.
Publicado: (2020)

Mortality associated with cardiovascular disease in patients with COVID-19()
por: Cordero, Alberto, et al.
Publicado: (2021)

Early warning of epidemics: towards a national intelligent syndromic surveillance system (NISSS) in China
por: Jia, Peng, et al.
Publicado: (2020)

Impact of COVID-19 pandemic on cardiovascular diseases hospitalisation, management and mortality in Switzerland
por: Maung, Ko Ko, et al.
Publicado: (2023)

Chronic Anti-Coagulation Therapy Reduced Mortality In Patients With High Cardiovascular Risk Early In COVID-19 Pandemic
por: Zaghloul, Mohamed S., et al.
Publicado: (2022)

Chronic anti-coagulation therapy reduced mortality in patients with high cardiovascular risk early in COVID-19 pandemic
por: Zaghloul, Mohamed S., et al.
Publicado: (2023)

Moving towards a precision approach for prevention of severe COVID-19
por: Branch-Elliman, Westyn, et al.
Publicado: (2023)

CARDIOVASCULAR AND MORTALITY OUTCOMES IN ONCOLOGY PATIENTS HOSPITALIZED WITH COVID-19
por: Kwan, Jennifer, et al.
Publicado: (2021)

Analysis of Mortality in Unvaccinated Patients with COVID-19 and Cardiovascular Risk
por: Sarzyńska, Kathie, et al.
Publicado: (2022)

Pitfalls in Modeling Asymptomatic COVID-19 Infection
por: Yang, Shujuan, et al.
Publicado: (2021)

Toward a More Precise Understanding of Obesity and Cancer and Cardiovascular Disease Risk
por: Reding, Kerryn W., et al.
Publicado: (2022)

Social Capital Changes After COVID-19 Lockdown Among Youths in China: COVID-19 Impact on Lifestyle Change Survey (COINLICS)
por: Yu, Bin, et al.
Publicado: (2021)

Cost-effectiveness of risk stratified medication management for reducing premature cardiovascular mortality in Kenya
por: Subramanian, Sujha, et al.
Publicado: (2019)

Towards precision medicine: The application of omics technologies in asthma management
por: Scelfo, Chiara, et al.
Publicado: (2018)

Contemporary management of pain in cirrhosis: Toward precision therapy for pain
por: Holman, Alexis, et al.
Publicado: (2023)

Towards precision medicine for sepsis patients
por: Pickkers, Peter, et al.
Publicado: (2017)

Impact of COVID-19 Lockdown on Physical Activity Among the Chinese Youths: The COVID-19 Impact on Lifestyle Change Survey (COINLICS)
por: Zhou, Junmin, et al.
Publicado: (2021)

Changes in patterns of take-away food ordering among youths before and after COVID-19 lockdown in China: the COVID-19 Impact on Lifestyle Change Survey (COINLICS)
por: Luo, Miyang, et al.
Publicado: (2021)

The clinical value of quantitative cardiovascular molecular imaging: a step towards precision medicine
por: Tingen, Hendrea Sanne Aletta, et al.
Publicado: (2023)

Remdesivir Reduces Mortality in Hemato-Oncology Patients with COVID-19
por: Aksak-Wąs, Bogusz Jan, et al.
Publicado: (2022)

COVID-19 vaccination reduces mortality in patients on maintenance hemodialysis
por: Tylicki, Leszek, et al.
Publicado: (2022)

Increased cardiovascular mortality in African Americans with COVID-19
por: McGonagle, Dennis, et al.
Publicado: (2020)

Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
por: Mehra, Mandeep R., et al.
Publicado: (2020)

COVID-19: RACIAL DISPARITY AND CARDIOVASCULAR COMORBIDITIES THAT PREDICT MORTALITY
por: Omeh, Demian Jideofor, et al.
Publicado: (2021)

Correction: Cost-effectiveness of risk stratified medication management for reducing premature cardiovascular mortality in Kenya
Publicado: (2020)

Attenuating the Variability of Lipids Is Beneficial for the Hypertension Management to Reduce the Cardiovascular Morbidity and Mortality in Older Adults
por: Dong, Yuanli, et al.
Publicado: (2021)

Trend towards reduction in COVID-19 in-hospital mortality
por: Ruggeri, Annalisa, et al.
Publicado: (2021)

Does hydroxychloroquine reduce mortality for COVID-19?
por: GALLUS, Silvano, et al.
Publicado: (2020)

Does melatonin reduce mortality in COVID-19?
por: Pilia, Eros, et al.
Publicado: (2022)

Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular Mortality
por: Shahab, Omer, et al.
Publicado: (2018)

Association between pre-existing cardiovascular disease, mortality and cardiovascular outcomes in hospitalised patients with COVID-19
por: Sritharan, Hari P., et al.
Publicado: (2023)

Mental disorders and COVID-19: Towards a precision public mental health approach
por: Stein, Dan J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_km1lk9o9r97qhcjbrgao5cedaf